Tonix Pharmaceuticals Holding Corp. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.6M, a 44.7% increase year-over-year.
  • Tonix Pharmaceuticals Holding Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$142M, a 14.4% decline year-over-year.
  • Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2023 was -$118M, a 5.61% decline from 2022.
  • Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2022 was -$112M, a 21.4% decline from 2021.
  • Tonix Pharmaceuticals Holding Corp. annual Operating Income (Loss) for 2021 was -$92.3M, a 82.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$142M -$15.6M +$12.6M +44.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$154M -$77.3M -$48.3M -167% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-16
Q1 2024 -$106M -$21.4M +$12.6M +37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$118M -$27.3M +$5.4M +16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$124M -$28.1M +$1.44M +4.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$125M -$29M -$5.67M -24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-16
Q1 2023 -$120M -$33.9M -$7.47M -28.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$112M -$32.7M -$3.25M -11% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$109M -$29.6M -$11.1M -59.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$97.8M -$23.3M +$226K +0.96% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$98M -$26.4M -$5.7M -27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$92.3M -$29.5M -$12.5M -73.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$79.9M -$18.5M -$6.54M -54.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$73.3M -$23.6M -$9.37M -66% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$64M -$20.7M -$13.4M -184% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$50.5M -$17M -$8.29M -94.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$42.2M -$12M -$4.11M -52.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$38.1M -$14.2M -$8.29M -140% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$29.8M -$7.3M -$1M -15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$28.8M -$8.73M -$1.08M -14.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$27.7M -$7.89M -$2.35M -42.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$25.4M -$5.91M +$237K +3.86% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$25.6M -$6.3M +$691K +9.89% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$26.3M -$7.65M -$2.11M -38% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$24.2M -$5.54M +$294K +5.04% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$24.5M -$6.14M -$1.32M -27.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$23.2M -$6.99M -$1.9M -37.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$21.3M -$5.54M +$1.97M +26.2% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-18
Q3 2017 -$23.3M -$5.84M +$1.77M +23.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$25M -$4.82M +$5.01M +51% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$30M -$5.09M +$8.92M +63.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$39M -$7.51M +$5.89M +44% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$44.9M -$7.61M +$5.67M +42.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$50.5M -$9.84M +$1.95M +16.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$52.5M -$14M -$4.32M -44.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$48.2M -$13.4M -$4.4M -48.8% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-03
Q3 2015 -$43.8M -$13.3M -$5.85M -78.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$37.9M -$11.8M -$5.74M -94.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$32.2M -$9.7M -$4.53M -87.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$27.7M -$9M -$5.3M -143% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-03
Q3 2014 -$22.4M -$7.43M -$4.34M -140% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-03
Q2 2014 -$18M -$6.05M -$3.96M -190% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-03
Q1 2014 -$14.1M -$5.17M -$3.17M -158% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-03
Q4 2013 -$10.9M -$3.71M -$1.68M -82.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 -$9.21M -$3.09M -$1.36M -78.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$7.85M -$2.09M -$352K -20.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$7.5M -$2M -$841K -72.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$6.66M -$2.03M -$538K -36% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$6.12M -$1.73M -$720K -71% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$5.4M -$1.73M -$1.38M -387% Apr 1, 2012 Jun 30, 2012 10-Q 2013-11-13
Q1 2012 -$4.03M -$1.16M -$647K -126% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 -$3.38M -$1.49M Oct 1, 2011 Dec 31, 2011 10-K/A 2013-11-22
Q3 2011 -$1.01M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$356K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$514K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.